UnitedHealth Group’s Challenges in 2026: Revenue Drops
UnitedHealth Group, a global leader in healthcare, has entered 2026 with mixed financial results and major strategic shifts. While the company met Q4 earnings expectations with an adjusted EPS of $2.11, it fell short on revenue, posting $113.2 billion against analysts’ expectations of $113.82 billion. The real headline for investors and industry observers, however, is UnitedHealth’s 2026 revenue guidance, which is projected to exceed $439 billion—representing a 2% decline, the first in over a decade.
What Led to the Revenue Decline?
The revenue drop can be attributed to three primary factors:
- Divestitures: UnitedHealth recently sold off operations in the UK and South America. More international divestments are expected this year as the company focuses on strengthening its domestic market presence.
- Membership Realignment: The company anticipates a loss of over 3 million members in 2026 as part of a “right-sizing” initiative. This includes raising premiums, exiting poorly performing markets, and scaling back on benefits in certain areas.
- Medicare’s V28 Coding Transition: 2026 marks the final year of Medicare’s transition to the new V28 coding system, which is expected to cost the company $6 billion in revenue.
Encouraging Signs: Cost Controls Improving
Despite the challenges, UnitedHealth has made significant progress in cost management. The medical benefit ratio—a key metric that measures healthcare costs against premiums collected—is projected to improve to 88.8% in 2026, down from 89.1% in 2025. This improvement indicates that the company’s cost-control measures, including adjustments to Medicare Advantage, are yielding results.
Medical costs from delayed surgeries and older adults returning to hospitals remain elevated but are stabilizing. Procedures like hip replacements and joint surgeries had been driving up costs during the post-pandemic recovery. CFO Wayne DeVeydt noted, “Q4 medical costs remain high but are no longer exceeding expectations.”
Medicare Advantage Rates Impact the Industry
The Centers for Medicare and Medicaid Services (CMS) announced a proposed 0.09% payment rate increase for Medicare Advantage plans for 2027. This has sent health insurer stocks, including UnitedHealth, down sharply, with some experiencing double-digit percentage declines. The low payment rate increase will limit what insurers can charge in premiums, squeezing profitability further.
In response, UnitedHealth has scaled back on Medicare Advantage offerings and doubled down on profitability by exiting specific markets where margins were thin. While the government will finalize rates in April, the proposed increase remains a concern for all major health insurers.
UnitedHealth’s Strategic Turnaround
Under the leadership of returning CEO Stephen Hemsley, UnitedHealth is rapidly reshaping its business. The company is focusing on domestic markets, shedding less profitable international operations while reinforcing its foundational strengths. Key priorities include building its balance sheet and boosting per-share profitability, with a 2026 adjusted profit forecast of over $17.75 per share.
To aid their transition, UnitedHealth is also addressing reputational and operational challenges stemming from federal probes, public mistrust, and controversies around insurance practices. While the path forward remains challenging, early indications suggest that the turnaround strategy is on track.
Discover Related Products: Medicare Planning Made Easy
If you’re navigating Medicare Advantage plans or need expert advice tailored to your needs, consider exploring Aetna Medicare Advantage plans, designed to balance cost efficiency with comprehensive coverage. This trusted provider can help you maximize your benefits and minimize out-of-pocket expenses.
UnitedHealth’s future will depend on its ability to regain investor confidence, stabilize memberships, and effectively manage the evolving Medicare landscape. Stay updated on the latest healthcare news to make informed decisions.
